Ali Tehrani

2019 - Zymeworks

In 2019, Ali Tehrani earned a total compensation of $3.3M as President and Chief Executive Officer at Zymeworks, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$341,930
Option Awards$2,375,128
Salary$540,788
Other$20,223
Total$3,278,069

Tehrani received $2.4M in option awards, accounting for 72% of the total pay in 2019.

Tehrani also received $341.9K in non-equity incentive plan, $540.8K in salary and $20.2K in other compensation.

Rankings

In 2019, Ali Tehrani's compensation ranked 3,719th out of 13,971 executives tracked by ExecPay. In other words, Tehrani earned more than 73.4% of executives.

ClassificationRankingPercentile
All
3,719
out of 13,971
73rd
Division
Manufacturing
1,343
out of 5,695
76th
Major group
Chemicals And Allied Products
467
out of 2,194
79th
Industry group
Drugs
392
out of 1,880
79th
Industry
Pharmaceutical Preparations
296
out of 1,392
79th
Source: SEC filing on March 23, 2020.

Tehrani's colleagues

We found four more compensation records of executives who worked with Ali Tehrani at Zymeworks in 2019.

2019

Kathryn O'Driscoll

Zymeworks

Chief People Officer

2019

Neil Klompas

Zymeworks

Chief Financial Officer

2019

Diana Hausman

Zymeworks

Chief Medical Officer

2019

Anthony Polverino

Zymeworks

Chief Scientific Officer

News

In-depth

You may also like